SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
2018 SESSION
HB 1440 Schedule I and Schedule II drugs; adds various drugs to lists.
Introduced by: T. Scott Garrett | all patrons ... notes | add to my profiles
SUMMARY AS INTRODUCED:
Schedule I and Schedule II drugs. Adds MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) to Schedule I of the Drug Control Act and Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration to Schedule II of the Drug Control Act and removes naldemedine from Schedule II of the Drug Control Act.
FULL TEXT
AMENDMENTS
HISTORY
- 01/16/18 House: Presented and ordered printed 18104387D
- 01/16/18 House: Referred to Committee on Health, Welfare and Institutions
- 01/25/18 House: Reported from Health, Welfare and Institutions (22-Y 0-N)
- 01/25/18 House: Referred to Committee on Appropriations
- 01/29/18 House: Assigned App. sub: Public Safety
- 02/08/18 House: Subcommittee recommends reporting (8-Y 0-N)
- 02/09/18 House: Reported from Appropriations (22-Y 0-N)
- 02/10/18 House: Read first time
- 02/12/18 House: Read second time and engrossed
- 02/13/18 House: Read third time and passed House BLOCK VOTE (100-Y 0-N)
- 02/13/18 House: VOTE: BLOCK VOTE PASSAGE (100-Y 0-N)
- 02/14/18 Senate: Constitutional reading dispensed
- 02/14/18 Senate: Referred to Committee on Education and Health
- 02/22/18 Senate: Reported from Education and Health (15-Y 0-N)
- 02/22/18 Senate: Rereferred to Finance
- 02/27/18 Senate: Reported from Finance with amendment (16-Y 0-N)
- 02/28/18 Senate: Constitutional reading dispensed (40-Y 0-N)
- 02/28/18 Senate: Read third time
- 02/28/18 Senate: Reading of amendment waived
- 02/28/18 Senate: Committee amendment agreed to
- 02/28/18 Senate: Engrossed by Senate as amended
- 02/28/18 Senate: Passed Senate with amendment (40-Y 0-N)
- 02/28/18 House: Senate amendment rejected by House (0-Y 94-N)
- 02/28/18 House: VOTE: REJECTED (0-Y 94-N)
- 02/28/18 Senate: Senate insisted on amendment (40-Y 0-N)
- 02/28/18 Senate: Senate requested conference committee
- 02/28/18 House: Placed on Calendar
- 02/28/18 House: House acceded to request
- 02/28/18 Senate: Conferees appointed by Senate
- 02/28/18 Senate: Senators: Peake, Dunnavant, Locke
- 02/28/18 House: Conferees appointed by House
- 02/28/18 House: Delegates: Garrett, Orrock, Aird
- 03/10/18 House: No further action taken
- 03/10/18 House: Failed to pass